The impact of tuberculosis and its treatment on the lung and gut microbiota: a global systematic review, meta-analysis, and amplicon-based metagenomic meta-analysis
Open Access
- 30 December 2025
- journal article
- review article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Abstract
Tuberculosis (TB) remains the leading cause of bacterial disease-related mortality worldwide. While Koch’s single-agent model has long guided TB diagKeywords
This publication has 45 references indexed in Scilit:
- Airway microbiome signature accurately discriminates Mycobacterium tuberculosis infection statusiScience, 2024
- Gut microbiome in modulating immune checkpoint inhibitorsEBioMedicine, 2022
- Microbiota in health and diseasesSignal Transduction and Targeted Therapy, 2022
- Exploring the universal healthy human gut microbiota around the WorldComputational and Structural Biotechnology Journal, 2021
- QIIME 2 Enables Comprehensive End‐to‐End Analysis of Diverse Microbiome Data and Comparative Studies with Publicly Available DataCurrent Protocols in Bioinformatics, 2020
- The microbiome and tuberculosis: state of the art, potential applications, and defining the clinical research agendaThe Lancet Respiratory Medicine, 2019
- The microbiota of the respiratory tract: gatekeeper to respiratory healthNature Reviews Microbiology, 2017
- The role of the microbiome in exacerbations of chronic lung diseasesThe Lancet, 2014
- Diversity, stability and resilience of the human gut microbiotaNature, 2012
- The spectrum of latent tuberculosis: rethinking the biology and intervention strategiesNature Reviews Microbiology, 2009